Organogenesis Holdings Inc (ORGO)
4.00
-0.43
(-9.71%)
USD |
NASDAQ |
Nov 14, 16:00
4.00
0.00 (0.00%)
After-Hours: 16:47
Organogenesis Holdings Price to Book Value: 2.013 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 2.229 |
| November 12, 2024 | 1.736 |
| November 11, 2024 | 1.761 |
| November 08, 2024 | 1.650 |
| November 07, 2024 | 1.640 |
| November 06, 2024 | 1.615 |
| November 05, 2024 | 1.530 |
| November 04, 2024 | 1.504 |
| November 01, 2024 | 1.399 |
| October 31, 2024 | 1.394 |
| October 30, 2024 | 1.454 |
| October 29, 2024 | 1.499 |
| October 28, 2024 | 1.484 |
| October 25, 2024 | 1.409 |
| October 24, 2024 | 1.444 |
| October 23, 2024 | 1.454 |
| October 22, 2024 | 1.560 |
| October 21, 2024 | 1.565 |
| October 18, 2024 | 1.590 |
| October 17, 2024 | 1.545 |
| October 16, 2024 | 1.635 |
| October 15, 2024 | 1.61 |
| October 14, 2024 | 1.555 |
| October 11, 2024 | 1.545 |
| October 10, 2024 | 1.459 |
| Date | Value |
|---|---|
| October 09, 2024 | 1.520 |
| October 08, 2024 | 1.504 |
| October 07, 2024 | 1.504 |
| October 04, 2024 | 1.550 |
| October 03, 2024 | 1.439 |
| October 02, 2024 | 1.434 |
| October 01, 2024 | 1.419 |
| September 30, 2024 | 1.439 |
| September 27, 2024 | 1.454 |
| September 26, 2024 | 1.419 |
| September 25, 2024 | 1.394 |
| September 24, 2024 | 1.464 |
| September 23, 2024 | 1.419 |
| September 20, 2024 | 1.424 |
| September 19, 2024 | 1.474 |
| September 18, 2024 | 1.434 |
| September 17, 2024 | 1.464 |
| September 16, 2024 | 1.439 |
| September 13, 2024 | 1.414 |
| September 12, 2024 | 1.313 |
| September 11, 2024 | 1.288 |
| September 10, 2024 | 1.288 |
| September 09, 2024 | 1.278 |
| September 06, 2024 | 1.243 |
| September 05, 2024 | 1.328 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9332
Minimum
Mar 24 2023
59.18
Maximum
Nov 15 2019
6.328
Average
3.154
Median
May 12 2022
Price to Book Value Benchmarks
| Poseida Therapeutics Inc | 5.127 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.8831 |
| Theriva Biologics Inc | 0.0530 |
Price to Book Value Related Metrics
| PS Ratio | 1.183 |
| Price to Free Cash Flow | 62.27 |
| Price | 4.00 |
| Earnings Yield | -3.36% |
| Market Cap | 530.30M |
| Operating PE Ratio | 44.81 |
| Normalized PE Ratio | 2610.97 |